Posiflex Announces Android 10 Google Mobile Services Certification for Kiosk Platforms
23.2.2021 06:00:00 EET | Business Wire | Press release
Posiflex Technology, Inc., a world leader in the design and manufacture of retail POS, kiosk, computing, and self-service transaction peripherals, is proud to announce a new Android 10 GMS certification, applicable to the kiosk portfolio of both Posiflex and KIOSK Information Systems (KIOSK).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210222005417/en/
Powered by POSIFLEX, Certified with GMS (Graphic: Business Wire)
Posiflex CEO Owen Chen notes, “This new Android 10 GMS certification milestone is quite significant. By offering GMS Certified kiosks, it allows Google Play and other GMS applications to be installed on our Android platforms. It streamlines onboarding onto Google’s proven and secure network, while unlocking kiosk access to the full suite of applications in the Google Play Store.”
Further, as mobile devices become increasingly pervasive in delivering retail and hospitality services, corporate Mobile Device Management (MDM) platforms rely on Android or iOS compatibility to optimize efficiencies within an edge device management ecosystem. Not a problem when considering mobile devices and tablets, but robust kiosk solutions require greater durability and significantly more ability to house transaction peripherals than are provided on commercial Android tablet devices. The Android 10 GMS certified kiosk platforms are equipped with ample computing and enough USB ports to power a kiosk platform with multiple integrated transaction peripherals.
KIOSK President Kim Kenney adds, “We have seen an increased demand among major retailers and hospitality clients for Android GMS capability to access Google Play Services to register and manage their kiosk fleet within their existing infrastructure. Through the certification efforts of the Posiflex R&D Team, both KIOSK and Posiflex can now provide best-in-class self-service features that can be consistently managed through existing Android OS networks. Without question, this provides niche competitive advantage and enables us to uniquely meet important new market requirements.”
About Posiflex Group, Inc.
Posiflex has designed and manufactured world-class POS solutions for more than 30 years. Since 2016, the company has acquired KIOSK and Portwell, further expanding into self-service and embedded PC offerings. The global Posiflex Group is in place to provide world-class B2B Serviced IoT solutions. For more information: www.posiflex.com
About KIOSK Information Systems
KIOSK provides self-service automation solutions to increase operational and cost efficiencies, while enhancing the customer experience. With over 27 years of experience and >250,000+ kiosks deployed, the company is a trusted digital transformation partner for Top 100 Retailers and Fortune 500 clients. KIOSK delivers proven expertise in design engineering and manufacturing, application development, integration, and comprehensive support services. An innovative portfolio of self-service solutions paired with managed services and IoT capabilities ensure a seamless user experience. Learn more at kiosk.com, 800.509.5471.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210222005417/en/
Contact information
Posiflex Group Press Contact (Taiwan): Brad Chou, marketing@posiflex.com.tw
KIOSK Press Contact (US): Cheryl Madeson, VP Marketing and Communications, cmadeson@kiosk.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release
With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release
Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom